Financials
- Market Capitalization 112.33 M
- Employee 25
- Founded 2013
- CEO Ankit Mahadevia
- Website www.sperotherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HXSJ1R2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
8.67
売上高対価格比率
2.22
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3866 | GNLX Genelux Corporation - Common Stock | 2.92 USD | -1.35% | -3.31% | -2.99% | -13.35% | 130.93 M USD | ||
| 3872 | SPRB Spruce Biosciences, Inc. - Common Stock | 48.01 USD | -0.76% | -6.23% | -5.64% | +336.45% | 132.14 M USD | ||
| 3882 | CUE Cue Biopharma, Inc. - Common Stock | 29.63 USD | -4.17% | -8.55% | +20.79% | +3798.68% | 119.87 M USD | ||
| 3883 | ENGN enGene Therapeutics Inc. - Common Stock | 1.90 USD | +2.15% | -0.52% | +8.57% | -77.38% | 127.28 M USD |